UTHR Exercise Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Aug 6, 2026
Exercise
Calculated transaction value
$0
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Aug 5, 2026
Public filing date
Aug 6, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$519.01
Aug 5, 2026
Close before public filing
$519.01
Aug 5, 2026
Return since public filing
-4.22%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option on Common Stock
- Quantity / price
- 9,500 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001106578-26-000114
Filing cohort
Transactions in this filing
Showing 15 of 18
Trades
18
Issuers
1
Estimated value
$6.21M
Buys / sales
0 / 16
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Aug 5, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Aug 5, 2026 | $100.46K |
| United Therapeutics Corp UTHR | Sale | Aug 5, 2026 | $40.34K |
| United Therapeutics Corp UTHR | Sale | Aug 5, 2026 | $81.64K |
| United Therapeutics Corp UTHR | Sale | Aug 5, 2026 | $272.05K |
| United Therapeutics Corp UTHR | Sale | Aug 5, 2026 | $105.67K |
| United Therapeutics Corp UTHR | Sale | Aug 5, 2026 | $199.46K |
| United Therapeutics Corp UTHR | Sale | Aug 5, 2026 | $288.24K |
| United Therapeutics Corp UTHR | Sale | Aug 5, 2026 | $777.35K |
| United Therapeutics Corp UTHR | Sale | Aug 5, 2026 | $490.78K |
| United Therapeutics Corp UTHR | Sale | Aug 5, 2026 | $136.73K |
| United Therapeutics Corp UTHR | Sale | Aug 5, 2026 | $83.93K |
| United Therapeutics Corp UTHR Current | Exercise | Aug 5, 2026 | $0 |
| United Therapeutics Corp UTHR | Sale | Aug 5, 2026 | $980.5K |
| United Therapeutics Corp UTHR | Sale | Aug 5, 2026 | $81.16K |